CCS/CHFS Heart Failure Guidelines: Clinical Trial Update on Functional Mitral Regurgitation, SGLT2 Inhibitors, ARNI in HFpEF, and Tafamidis in Amyloidosis
Titel:
CCS/CHFS Heart Failure Guidelines: Clinical Trial Update on Functional Mitral Regurgitation, SGLT2 Inhibitors, ARNI in HFpEF, and Tafamidis in Amyloidosis
Auteur:
O’Meara, Eileen McDonald, Michael Chan, Michael Ducharme, Anique Ezekowitz, Justin A. Giannetti, Nadia Grzeslo, Adam Heckman, George A. Howlett, Jonathan G. Koshman, Sheri L. Lepage, Serge Mielniczuk, Lisa M. Moe, Gordon W. Swiggum, Elizabeth Toma, Mustafa Virani, Sean A. Zieroth, Shelley De, Sabe Matteau, Sylvain Parent, Marie-Claude Asgar, Anita W. Cohen, Gideon Fine, Nowell Davis, Margot Verma, Subodh Cherney, David Abrams, Howard Al-Hesayen, Abdul Cohen-Solal, Alain D’Astous, Michel Delgado, Diego H. Desplantie, Olivier Estrella-Holder, Estrellita Green, Lee Haddad, Haissam Harkness, Karen Hernandez, Adrian F. Kouz, Simon LeBlanc, Marie-Hélène Lee, Douglas Masoudi, Frederick A. McKelvie, Robert S. Rajda, Miroslaw Ross, Heather J. Sussex, Bruce